| 1 |
33521468 | Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth. | 2021 Jan 26 |
1 |
| 2 |
29400967 | Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. | 2018 Jul 26 |
1 |
| 3 |
26713112 | Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety. | 2015 Dec 10 |
1 |
| 4 |
24412109 | Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker. | 2014 Feb 1 |
1 |
| 5 |
21524576 | 2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity. | 2011 Jun 1 |
1 |
| 6 |
19914064 | Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines. | 2010 Jan 1 |
1 |
| 7 |
18996007 | The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing. | 2008 Dec 15 |
1 |
| 8 |
17188866 | Constrained 7-fluorocarboxychromone-4-aminopiperidine based Melanin-concentrating hormone receptor 1 antagonists: the effects of chirality on substituted indan-1-ylamines. | 2007 Feb 15 |
1 |
| 9 |
17303420 | The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents. | 2007 Apr 15 |
1 |
| 10 |
15566305 | Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel. | 2004 Dec 2 |
1 |